top of page



2022  2021  2020  2019  2018


2017  2016  2015       2014       2013 


2012  2011  2010       2009       2008


  • Munakata L, Tanimoto Y, Osa A, Meng J, Haseda Y, Naito Y, Machiyama H, Kumanogoh A, Omata D, Maruyama K, Yoshioka Y, Okada Y, Koyama S, Suzuki R, Aoshi T. Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice. J Control Release. 2019, 313, 106-119.

  • Omata D, Maruyama T, Unga J, Hagiwara F, Munakata L, Kageyama S, Shima T, Suzuki Y, Maruyama K, Suzuki R. Effects of encapsulated gas on stability of lipid-based microbubbles and ultrasound-triggered drug delivery. J Control Release. 2019, 311-312, 65-73.

  • Unga J, Kageyama S, Suzuki R, Omata D, Maruyama K. Scale-up production, characterization and toxicity of a freeze-dried lipid-stabilized microbubble formulation for ultrasound imaging and therapy. J Liposome Res. 2019, 7, 1-8.

  • Hamano N, Kamoshida S, Kikkawa Y, Yano Y, Kobayashi T, Endo-Takahashi Y, Suzuki R, Maruyama K, Ito Y, Nomizu M, Negishi Y. Development of Antibody-Modified Nanobubbles Using Fc-Region-Binding Polypeptides for Ultrasound Imaging. Pharmaceutics. 2019, 11, pii: E283.

  • Unga J, Omata D, Kudo N, Ueno S, Munakata L, Shima T, Suzuki R, Maruyama K. Development and evaluation of stability and ultrasound response of DSPC-DPSG-based freeze-dried microbubbles. J Liposome Res. 2019, 29, 368-374.

  • Seki, M, Otsuka T, Oitate R, Masuda K, Unga J, Suzuki R, Maruyama K. Viability validation of therapeutic cells according to surrounded amount of microbubbles and ultrasound exposure condition. Jpn. J. Appl. Phys. 2019, 58, SGGE13.

bottom of page